¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѰǼ±ÇÐȸ Á¦25Â÷ Çмú´ëȸ : 2022-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѰǼ±ÇÐȸ Á¦25Â÷ Çмú´ëȸ : 2022-09-03
±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : ÄÚ¿¢½º ÄÁº¥¼Ç ÄÁÆÛ·±½º·ë(³²) 4Ãþ ±×·£µå ÄÁÆÛ·±½º·ë(401È£), 403È£  
±³À°ÁÖÁ¦ : ´ëÇѰǼ±ÇÐȸ Á¦25Â÷ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѰǼ±ÇÐȸ  
´ã´çÀÚ : ¹éÀ¯»ó
¿¬¶ôó : 02-2626-1308  
À̸ÞÀÏ : seemind@naver.com      
±³À°Á¾·ù : ÇǺΰú      
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 500,000¿ø      
ºñ°í »çÀüµî·Ï Á¤È¸¿ø 5¸¸¿ø, ÁØȸ¿ø 2¸¸¿ø, ÇǺΰú ÀÌ¿Ü Å¸°ú 50¸¸¿ø / ÇöÀåµî·Ï Á¤È¸¿ø 6¸¸¿ø, ÁØȸ¿ø 3¸¸¿ø, ÇǺΰú ÀÌ¿Ü Å¸°ú 50¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 403È£ 09:30~09:50 Updates in Genetics of Psoriasis and Its Subtypes  ¹éÀ¯»ó(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-03 403È£ 09:50~10:10 Updates in Immunopathogenesis  ¹ÚÀºÁÖ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-03 403È£ 10:10~10:30 Oxidative stress in the pathogenesis of psoriasis  ±èűÕ(¿¬¼¼ÀÇ´ë) 
±âŸ 09-03 401È£ 09:30~10:30 ÀÚÀ¯¿¬Á¦  () 
È޽Ġ09-03  10:30~10:40 È޽Ġ () 
±³À°½Ã°£ 09-03 401È£, 403È£ 10:40~11:10 Understanding disease modification in psoriasis  James G. Krueger(Rockefeller Univeristy, USA) 
±³À°½Ã°£ 09-03 401È£, 403È£ 11:10~11:40 Dynamics of inflammatory cytokines in generalized pustular psoriasis  Kazumitsu Sugiura(Fujita Health University Hospital, Japan) 
±³À°½Ã°£ 09-03 401È£, 403È£ 11:40~12:10 Current Knowledge of the Interrelationship between IBD and psoriasis  °í¼ºÁØ(¼­¿ïÀÇ´ë) 
È޽Ġ09-03  12:10~12:20 È޽Ġ () 
±³À°½Ã°£ 09-03 401È£, 403È£ 12:20~12:50 Consideration in the selection of anti-psoriatic therapy  Melinda Gooderham(Queen's University, Canada) 
½Ä»ç 09-03  12:50~13:30 ½Ä»ç  () 
±³À°½Ã°£ 09-03 401È£, 403È£ 13:30~14:00 What I have done for the study of Psoriasis  ±èÅÂÀ±(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 401È£, 403È£ 14:00~14:30 Psoriasis today and for a better tomorrow  ¼ÛÇØÁØ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-03 401È£ 14:30~14:50 Potential biomarkers for psorisis  ±èÁ¤Àº(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 09-03 401È£ 14:50~15:10 Geriatric patients with psoriasis  Á¤°æÀº(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 401È£ 15:10~15:30 Pediatric patients with psoriasis  ±è¼º¾Ö(°è¸íÀÇ´ë) 
±âŸ 09-03 403È£ 14:30~15:30 ¿ª»ç¸¦ ÀØÀº ¹ÎÁ·¿¡°Ô´Â ¹Ì·¡´Â ¾ø´Ù  ÇѸí±â(¸íÁö´ë) 
È޽Ġ09-03  15:30~15:50 È޽Ġ () 
±³À°½Ã°£ 09-03 403È£ 15:50~16:10 Pathologic role of IL23/IL17 in psoriatic arthritis  ÃÖÀ¯¼º(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 403È£ 16:10~16:30 Beware of cardiovascular and metabolic diseases comorbid with psoriasis  Á¤±âÇå(°æÈñÀÇ´ë) 
±³À°½Ã°£ 09-03 403È£ 16:30~16:50 Mental health disorder associated with psoriasis  ¹æöȯ(°¡Å縯ÀÇ´ë) 
±âŸ 09-03 401È£ 15:50~16:50 ÀÚÀ¯¿¬Á¦  () 
±³À°½Ã°£ 09-03 401È£ 16:50~17:20 ÆÇ»ó °Ç¼±ÀÇ Ä¡·á ¸ñÇ¥ - µ¨ÆÄÀÌ È¸ÀÇ °á°úº¸°í  ÀÌÀº¼Ò(¾ÆÁÖÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѰǼ±ÇÐȸ Á¦25Â÷ Çмú´ëȸ : 2022-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦18ȸ °í½Å´ëÇб³ º¹À½º´¿ø ³»°ú ¿¬¼ö°­Á : 2022-09-03
´ÙÀ½±Û Á¦1Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Áß°³¿¬±¸ ½ÉÆ÷Áö¾ö : 2022-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 4 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 6 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 109 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 11 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 42 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 11 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 7 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 6 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 4 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 7 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 9 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 3 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 9 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷